產品編號 | bsm-52197R |
英文名稱 | Phospho-Rb (Ser807) Recombinant Rabbit mAb |
中文名稱 | 磷酸化視網(wǎng)膜母細胞瘤相關蛋白1重組兔單抗 |
別 名 | RB_HUMAN; Retinoblastoma-associated protein; RB1; p105-Rb; p110-RB1; pRb (Rb); pp110; RB transcriptional corepressor 1; pRb; OSRC; PPP1R130; Retinoblastoma; |
![]() |
Specific References (1) | bsm-52197R has been referenced in 1 publications.
[IF=6.208] Molin Li. et al. PPP3R1 Promotes MSCs Senescence by Inducing Plasma Membrane Depolarization and Increasing Ca2+ Influx. INT J MOL SCI. 2023 Jan;24(5):4421 WB ; Mouse.
|
產品類型 | 磷酸化抗體 重組兔單抗 |
研究領域 | 腫瘤 細胞生物 免疫學 轉錄調節(jié)因子 |
抗體來源 | Rabbit |
克隆類型 | Recombinant |
克 隆 號 | 2D10 |
交叉反應 | Human (predicted: Mouse,Rat) |
產品應用 | WB=1:500-2000,IHC-P=1:50-200,IHC-F=1:50-200,IF=1:50-200,ICC/IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理論分子量 | 102 kDa |
檢測分子量 | |
細胞定位 | 細胞核 |
性 狀 | Liquid |
濃 度 | 1mg/ml |
免 疫 原 | KLH conjugated Synthesised phosphopeptide derived from human Rb around the phosphorylation site of Ser807: YI(p-S)PLK |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產品介紹 |
Rb is a tumor suppressor gene which functions as a negative regulator of the cell cycle by interacting with transcription factors including E2F1, PU1, ATF2, UBF, Elf1 and cAbl. This ability of Rb to alter transcription is regulated by phosphorylation catalyzed by the cyclin dependent protein kinases (cdks). Rb is phosphorylated on serine and threonine, but not on tyrosine residues. It forms a complex with SV40 large T antigen, adenovirus E1A, and human papilloma virus 16E. Rb protein may act by regulating transcription and loss of its function leads to uncontrolled cell growth. Aberrations in the Rb gene have been implicated in cancers of breast, colon, prostate, kidney, nasopharynx, and leukemia. Function: Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, SUV420H1 and SUV420H2, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. Subunit: Interacts with ATAD5. Interacts with PRMT2, CDK1 and CDK2. The hypophosphorylated form interacts with and sequesters the E2F1 transcription factor. Interacts with heterodimeric E2F/DP transcription factor complexes containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or TFDP2 and E2F4. The unphosphorylated form interacts with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-terminal domain of TAF1. Interacts with AATF, DNMT1, LIN9, LMNA, SUV420H1, SUV420H2, PELP1 and TMPO-alpha. May interact with NDC80. Interacts with GRIP1 and UBR4. Interacts with ARID4A and KDM5B. Interacts with E4F1 and LIMD1. Interacts with SMARCA4/BRG1 AND HDAC1. Interacts with adenovirus E1A protein, HPV E7 protein and SV40 large T antigen. Interacts with PSMA3 and USP4. Interacts (when methylated at Lys-860) with L3MBTL1. Subcellular Location: Nucleus. Tissue Specificity: Expressed in the retina. Post-translational modifications: Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-567 in G1, thereby releasing E2F1 which is then able to activate cell growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV E7 and adenovirus E1A bind to the underphosphorylated, active form of pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction between the C-terminal domain C and the Pocket domain, and thereby inhibits interactions with heterodimeric E2F/DP transcription factor complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis. N-terminus is methylated by METTL11A/NTM1. Monomethylated at Lys-860 by SMYD2, promoting interaction with L3MBTL1. DISEASE: Defects in RB1 are the cause of childhood cancer retinoblastoma (RB) [MIM:180200]. RB is a congenital malignant tumor that arises from the nuclear layers of the retina. It occurs in about 1:20'000 live births and represents about 2% of childhood malignancies. It is bilateral in about 30% of cases. Although most RB appear sporadically, about 20% are transmitted as an autosomal dominant trait with incomplete penetrance. The diagnosis is usually made before the age of 2 years when strabismus or a gray to yellow reflex from pupil ('cat eye') is investigated. Defects in RB1 are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences. Defects in RB1 are a cause of osteogenic sarcoma (OSRC) [MIM:259500]. Similarity: Belongs to the retinoblastoma protein (RB) family. SWISS: P06400 Gene ID: 5925 Database links: Entrez Gene: 5925 Human Entrez Gene: 19645 Mouse Omim: 614041 Human SwissProt: P06400 Human SwissProt: P13405 Mouse Unigene: 408528 Human Unigene: 273862 Mouse Unigene: 55115 Rat |
產品圖片 |
Paraformaldehyde-fixed, paraffin embedded (human colon carcinoma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (Phospho-Rb (Ser807)) Monoclonal Antibody, Unconjugated (bsm-52197R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
|
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關于肽鏈的設計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |
| 亚洲男人天堂av | 成人做爰xXX视频看片 | 无码人妻精品一区二区蜜桃色欲 | 黄色视频大全高清国产 | 亚洲A V电影一区 | 99国产揄拍国产精品 | 成人无码区免费A片久久鸭软件 | 少妇搡BBBB搡BBBB毛多多 | 免费毛片网站在线观看 | 国产精品探花一区二区在线观看 | 91无码人妻精品1国产 | 特级丰满少妇一级AAA爱毛片 | 三级片在线观看网站网址大全 | 中文无码人妻AV素人 | 国产精品日日摸天天碰 | 亚洲国产精品无码久久久久 | 亚洲高清一区二区论理片 | 欧美人与性囗牲恔配 | 国产超清一区二区三区 | 91人人妻人人做人人爽京东 | 北京熟妇槡BBBB槡BBBB | 亲子乱伦一区二区三区 | 午夜福利视频色视频在线 | 97人妻精品一区二区三区动漫 | av无码在线免费观看 | 国产麻豆剧传媒精品国产AV | 欧美日韩另类暴露女视频 | 又粗又黄又大免费视频 | 少妇高潮免费看一级A片出水图片 | 蜜桃在线码无精品秘入口九色 | 国产美女遭强高潮开双腿网站小说在线观看 | 蜜桃视频网站一区二区三区 | 欧美精品无码久久久一区二区三区专区 | 蜜桃Av一区二区精品 | 黄色av网站在线观看 | 国产女人喷水视频在线观看 | 91丨九色丨丰满熟女首页 | 成人A片产无码免费视频奶头麻豆 | 四川少妇BBw搡BBBB槡BBBB 四川少妇bbw搡bbbb搡bbbb | 精品无码又粗又大又长小说 |